ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Rheumatology

Top Rheumatology Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
FREDERICK MURPHY DO

Rheumatology

7,662

$1.56M

803
592 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 23%

$204
Average prescription price

Avg: $156

MARK CRUCIANI MD

Rheumatology

7,445

$961K

543
324 are 65+

27%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$129
Average prescription price

Avg: $156

RONALD SCHLANSKY MD

Rheumatology

6,835

$741K

581
483 are 65+

2%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$108
Average prescription price

Avg: $156

DAVID CHESNER D.O.

Rheumatology

6,617

$892K

564
400 are 65+

15%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$135
Average prescription price

Avg: $156

JULIO RAMOS MD

Rheumatology

6,577

$850K

736
462 are 65+

17%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$129
Average prescription price

Avg: $156

ANGELA STUPI M.D., PH.D.

Rheumatology

6,331

$1.04M

602
467 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 8%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 23%

$164
Average prescription price

Avg: $156

LEO BIDULA M.D.

Rheumatology

6,248

$668K

947
777 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

23%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$107
Average prescription price

Avg: $156

THOMAS KANTOR M.D.

Rheumatology

6,101

$517K

469
325 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$85
Average prescription price

Avg: $156

KEITH SHENBERGER MD

Rheumatology

5,967

$690K

497
353 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 23%

$116
Average prescription price

Avg: $156

LORI LAVELLE DO

Rheumatology

5,954

$848K

571
343 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$142
Average prescription price

Avg: $156

EUGENE GRADY M.D.

Rheumatology

5,648

$871K

550
398 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$154
Average prescription price

Avg: $156

FAROOQ HASSAN MD

Rheumatology

5,490

$761K

465
288 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 8%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 23%

$139
Average prescription price

Avg: $156

ALAN KIVITZ MD

Rheumatology

5,269

$843K

765
552 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 23%

$160
Average prescription price

Avg: $156

MARIANNE SANTIONI DO

Rheumatology

5,212

$1.03M

395
209 are 65+

22%
patients receiving schedule two controlled substances

Avg: 6%

20%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 23%

$198
Average prescription price

Avg: $156

DAVID SEAMAN MD

Rheumatology

5,200

$1.2M

639
459 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$230
Average prescription price

Avg: $156

MAGDY ISKANDER M.D.

Rheumatology

5,129

$764K

512
417 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$149
Average prescription price

Avg: $156

AJAY MATHUR M.D.

Rheumatology

5,016

$638K

510
403 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

3%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$127
Average prescription price

Avg: $156

DAVID TROSTLE M.D.

Rheumatology

5,014

$482K

564
439 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$96
Average prescription price

Avg: $156

MARIANNE SHAW M.D.

Rheumatology

4,777

$780K

495
353 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$163
Average prescription price

Avg: $156

CHARLES PUCEVICH MD

Rheumatology

4,570

$754K

468
374 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$165
Average prescription price

Avg: $156

DAVID FRANCOIS MD

Rheumatology

4,531

$269K

451
347 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $156

VERONICA NEWSOME DO

Rheumatology

4,519

$753K

392
234 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$167
Average prescription price

Avg: $156

THOMAS WHALEN DO

Rheumatology

4,424

$949K

347
174 are 65+

40%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 8%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$214
Average prescription price

Avg: $156

LISA ALLEN M.D.

Rheumatology

4,272

$696K

425
321 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$163
Average prescription price

Avg: $156

BRUCE HOFFMAN

Rheumatology

4,204

$714K

431
323 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$170
Average prescription price

Avg: $156

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank